Restricted accessResearch articleFirst published online 2001-07
Comparison between noradrenergic and serotonergic medications using the Social Adjustment Scale: is drive enhancement necessary for recovery of social functioning?
The Social Adjustment Scale (SAS) was used to assess social functioning sequentially over 13 weeks in a group of 188 depressed outpatients randomized to either the noradrenergic antidepressant, nortriptyline, or the selective serotonin reuptake inhibitor, fluoxetine. Over the period of 13 weeks, there were no differences in total SAS scores between the nortriptyline and the fluoxetine group. In comparing the SAS subscale scores, which may measure different areas of motivation and behaviour (drive), there were differences between the two groups in only two subscales. At 13 weeks, the group randomized to fluoxetine were more impaired in marital role (p = 0.026) whereas, at 6 weeks, the group randomized to nortriptyline were more impaired in friction scores (p = 0.012). These results do not support the concept of specific augmentation of drive-related behaviour by noradrenergic medication. This challenges the earlier findings relating to drive enhancement and social adjustment using such medication.
Bauwens F, Tracy A, Pardoen D, Vander Elst M, Mendlewicz J (1991) Social adjustment of remitted bipolar and unipolar outpatients. A comparison with age-and sex-matched controls. Br J Psychiatry159: 239–244
2.
Bigeon A (1984) The complex binding of tricyclic antidepressants to rat brain: the case of nortriptyline. Brain Res321(2): 347–351
3.
Bolden-Watson C, Richelson E (1993) Blockade by newly developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci52: 1023–1029
4.
Bosc M, Dubini A, Polin V (1997) Development and validation of a social functioning scale, the Social Adaptation Self-evaluation Scale. Eur Neuropsychopharmacol7: S57–S73
5.
Bothwell S, Weissman M M (1977) Social impairments four years after an acute depressive episode. Am J Orthopsychiatry47: 231–237
6.
Cleare A J, Bond A J (1997) Does central serotonergic function correlate inversely with aggression? A study using D-fenfluramine in healthy subjects. Psychiatry Res69: 89–95
7.
Coccaro E F, Kavoussi R J (1997) Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch Gen Psychiatry54: 1081–1088
8.
Coccaro E F, Kavoussi R J, Trestman R L, Gabriel S M, Cooper T B, Siever L J (1997) Serotonin function in human subjects: intercorrelations among central 5-HT indices and aggressiveness. Psychiatry Res73: 1–14
9.
Coccaro E F, Kavoussi R J, Hauger R L, Cooper T B, Ferris C F (1998) Cerebrospinal fluid vasopressin levels: correlates with aggression and serotonin function in personality-disordered subjects. Arch Gen Psychiatry55: 708–714
10.
Cooper P, Osborn M, Gath D, Feggetter G (1982) Evaluation of a modified self-report measure of social adjustment. Br J Psychiatry141: 68–75
11.
Derogatis L R, Lipman R S, Covi L (1973) SCL-90: an outpatient psychiatric rating scale – preliminary report. Psychopharmacol Bull9: 13–28
12.
Dobson K S (1987) Marital and social adjustment in depressed and remarried women. J Clin Psychol43: 261–265
13.
Dubini A, Bosc M, Polin V (1997a) Do noradrenaline and serotonin differentially affect social motivation and behaviour?Eur Neuropsychopharmacol7: S49–S55; discussion S71–S73
14.
Dubini A, Bosc M, Polin V (1997b) Noradrenaline-selective versus serotonin-selective antidepressant therapy: differential effects on social functioning. J Psychopharmacol11: S17–S23
15.
Edwards D W, Yarvis R M, Mueller D P, Zingale H C, Wagman W J (1978) Test-taking and the stability of adjustment scales: can we assess patient deterioration?Eval Q2: 275–291
16.
Fava M (1998) Depression with anger attacks. J Clin Psychiatry59: 18–22
17.
Fava M, Rosenbaum JF (1998) Anger attacks in depression. Depress Anxiety8: 59–63
18.
Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry23: 56–62
19.
Healy D, McMonagle T (1997) The enhancement of social functioning as a therapeutic principle in the management of depression. J Psychopharmacol11: S25–S31
20.
Healy D, Healy H (1998) The clinical pharmacologic profile of reboxetine: does it involve the putative neurobiological substrates of wellbeing?J Affect Disord51: 313–322
21.
Hirschfeld R M (2000) History and evolution of the monoamine hypothesis of depression. J Clin Psychiatry61: 4–6
22.
Luty S E, Joyce P R, Mulder R T, McKenzie J M (2001) Social adjustment in depression: the impact of depression severity, personality, and clinic versus community sampling. J Affect DIS, in press
23.
Maas J W (1975) Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression. Arch Gen Psychiatry32: 1357–1361
24.
Manji H K (1992) G proteins: implications for psychiatry. Am J Psychiatry149: 746–760
25.
Massana J, Moller H J, Burrows G D, Montenegro R M (1999) Reboxetine: a double-blind comparison with fluoxetine in major depressive disorder. Int Clin Psychopharmacol14: 73–80
26.
Mauri M, Sarno N, Armani A, Rossi V M et al. (1991) Differential social adjustment correlates of axis I and axis II psychopathology in anxiety and depressive disorders. Eur Psychiatry6: 127–130
27.
Montgomery S A, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry134: 382–389
28.
Parker G B, Hadzi Pavlovic D, Wilhelm K, Hickie I, Brodaty H, Boyce P B (1994) Defining melancholia: properties of a refined sign based measure. Br J Psychiatry164: 316–326
29.
Patience D A, McGuire R J, Scott A I, Freeman C P (1995) The Edinburgh Primary Care Depression Study: personality disorder and outcome. Br J Psychiatry167: 324–330
30.
Paykel E S, Weissman M, Prusoff B A, Tonks C M (1971) Dimensions of social adjustment in depressed women. J Nerv Ment Dis152: 158–172
31.
Salzman C, Wolfson A N, Schatzberg A, Looper J, Henke R, Albanese M, Schwartz J, Miyawaki E (1995) Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. J Clin Psychopharmacol15: 23–29
32.
Schatzberg AF (1998) Noradrenergic versus serotonergic antidepressants: predictors of treatment response. J Clin Psychiatry59: 15–18
33.
Shea M T, Elkin I, Imber S D, Sotsky S M, Watkins J T, Collins J F, Pilkonis P A, Beckham E, Glass D R, Dolan R T, Parloff M B (1992) Course of depressive symptoms over follow-up: findings from the National Institute of Mental Health Treatment of Depression Collaborative Research Program. Arch Gen Psychiatry49: 782–787
34.
Spitzer R L, Williams J B W, Gibbon M, First M B (1992) The structured Clinical Interview for DSM III R (SCID) I: history, rationale, and description. Arch Gen Psychiatry49: 624–629
35.
Stahl S M (1998) Not so selective serotonin reuptake inhibitors. J Clin Psychiatry59: 343–344
36.
Stewart J W, Quitkin F M, McGrath P J, Rabkin J G, Markowitz J S, Tricamo E, Klein D F (1988) Social functioning in chronic depression: effect of 6 weeks of antidepressant treatment. Psychiatry Res25: 213–222
37.
Weissman M M (1997) Beyond symptoms: social functioning and the new antidepressants (editorial). J Psychopharmacol11: S5–S8
38.
Weissman M M, Bothwell S (1976) Assessment of social adjustment by patient self-report. Arch Gen Psychiatry33: 1111–1115
39.
Weissman M M, Klerman G L, Paykel E S, Prusoff B, Hanson B (1974) Treatment effects on the social adjustment of depressed patients. Arch Gen Psychiatry30: 771–778
40.
Weissman M M, Prusoff B A, Thompson W D, Harding P S, Myers J K (1978) Social adjustment by self-report in a community sample and in psychiatric outpatients. J Nerv Ment Dis166: 317–326
41.
Weissman M M, Klerman G L, Prusoff B A, Sholomskas D, Padian N (1981a) Depressed outpatients. Results one year after treatment with drugs and/or interpersonal psychotherapy. Arch Gen Psychiatry38: 51–55
42.
Weissman M M, Sholomskas D, John K (1981b) The assessment of social adjustment. An update. Arch Gen Psychiatry38: 1250–1258
